The Board has recommended a final dividend of Rs. 65 per share for the financial year ended March 31,2025. Find enclosed the communication in this regard.
Awaiting price reaction for this filing.
The Board of Directors of Procter & Gamble Hygiene and Health Care Limited met on May 27, 2025 and approved the audited financial results for the period ended March 31, 2025. The Board has recommended a final dividend of Rs. 65 per equity share (on a face value of Rs. 10), aggregating to Rs. 21,099 lakhs, subject to shareholder approval at the 61st Annual General Meeting. The dividend is proposed to be paid between August 27, 2025 and September 23, 2025. The current reporting period is a 9-month transitional period because the company has shifted its financial year-end from June 30 to March 31. The Board also approved the appointment of M/s. M K Saraf & Associates LLP as Secretarial Auditors for five years from April 1, 2025 to March 31, 2030. Statutory auditors Kalyaniwalla & Mistry LLP issued an unmodified opinion on the financial results.
Shareholders stand to receive a Rs. 65 per share dividend payout subject to AGM approval, providing a steady income return. The dividend announcement along with an unmodified audit opinion reflects stable operational performance and supports positive investor sentiment.